Back to
Legal & General Group Plc
MCRB
Showing 0 of 23 quarters
Position history for
Legal & General Group Plc's holdings in SERES THERAPEUTICS INC
No. Legal & General Group exited its MCRB (Seres Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 9,985 shares worth $7,729. Legal & General Group already held MCRB in its Q4 2018 13F, the earliest on record, and held it in 22 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.